Nutriband Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
Nutriband Inc. granted U.S. patent for Aversa(TM) technology, enhancing abuse-deterrent transdermal products. Aversa Fentanyl aims to lead the market with safety innovations.
This development is crucial as it represents a significant advancement in the fight against opioid abuse, a major public health crisis. Nutriband's Aversa(TM) technology offers a promising solution to reduce the misuse and accidental exposure to potent drugs like fentanyl, potentially saving lives and reducing healthcare costs associated with drug abuse.
